Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for coronary slow flow phenomenon
IRCT20220223054103N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sildenafil in Slow Coronary Flow (SCF) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Clinical symptoms, ETT changes and 1 more. Started Jun 2022; status: completed.
02
Drugs
sildenafil
03
Conditions
Slow Coronary Flow (SCF)
Beyond the preview
Go deeper on IRCT20220223054103N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220223054103N1.